When you are considering antibiotic treatment for bacterial vs. viral infection
When your patient is visibly sick but lab tests are borderline, LIAISON® MeMed BV® gives you the easy-to-interpret scientific results that help confirm your diagnostic decision-making.
LIAISON® MeMed BV®
solves clinical uncertainty
LIAISON® MeMed BV®
solves clinical uncertainty
When there are diagnostics uncertainties
LIAISON® MeMed BV®
solves clinical uncertainty
When you need a “second opinion” or reassurance
LIAISON® MeMed BV®
solves clinical uncertainty
When you want to expedite a treatment decision
When to use the test
Suspected acute bacterial or viral infections
When to use the test
Probable Lower Respiratory Tract Infections
When to use the test
Pediatric patients 5 months and older
When to use the test
Urgent and Emergency care patients
When to use the test
Treatment management for hospitalized patients
How to interpret the test
B(Bacterial)
B(Bacterial)
0 ≤ score ≤10
High likelihood of viral infection (or other non-bacterial etiology)
10 < score <35
Moderate likelihood of viral infection (or other non-bacterial etiology)
35 ≤ score ≤ 65
Equivocal
65 < score < 90
Moderate likelihood of bacterial infection (or co-infection)
90 ≤ score ≤ 100
High likelihood of bacterial infection (or co-infection)
LIAISON® MeMed BV® measures and integrates three host-response protein signatures (TRIAL, IP-10 and CRP) to detect the presence of viral or bacterial microbes and support appropriate antibiotic use.
Why LIAISON® MeMed BV®
When used as the first step in clinical evaluation, LIAISON® MeMed BV® delivers targeted information to enhance treatment decisions, helping improve the overall quality of patient well-being.
OPERATIONAL BENEFITS
Enhance patient management
Improve ED patient flow and metrics
Improve utilization of other diagnostic tools
CLINICAL BENEFITS
Enhance patient management
Better patient hospital experience
Reduce likelihood of antibiotic misuse
ECONOMIC BENEFITS
Increase ROI
Reduce hospital costs
Simplify the diagnostic process
Talk to your lab about LIAISON® MeMed BV®
Quick discrimination between the bacterial and viral etiology of an infection is key to ensuring a better standard of care. And because LIAISON® MeMed BV® runs on the same LIAISON® platform already used in many laboratories around the world, adding it to your diagnostic work up is easy.
News and events
Labroots Webinar
“Bacterial or Viral? The added value of an innovative diagnostic solution for responsiveness when facing clinical uncertainties” available from 29.11.22
Poster
“LIAISON® MeMed BV®: a powerful diagnostic solution for the quick and easy differentiation of infection etiology” presented at 7th National Congress of Laboratory Medicine, which was held in Italy October 17th to 19th 2022
Poster
“Evaluation of LIAISON® MeMed BV® to discriminate bacterial and viral infections”
presented at the 27° Simposio annuale ELAS Italia – LIGAND ASSAY 2022 held on 21-23 November in Bologna, Italy
If you have any questions, inquires or if you need further information on the LIAISON® MedMed BV® assay, please leave your contact details by filling out the form below.